Evidence map›Paper›PMID 37031488›Full record

ArticleDrug and alcohol dependence2023

US drug overdose mortality rose faster among hispanics than non-hispanics from 2010 to 2021.

Ruby Romero, Joseph R Friedman, David Goodman-Meza, Chelsea L Shover

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Drug and alcohol dependence, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ruby RomeroDivision of General Internal Medicine and Health Services Research, University of California, Los Angeles, CA, USA.
Joseph R FriedmanUCLA David Geffen School of Medicine, Los Angeles, CA, USA.
David Goodman-MezaDivision of Infectious Diseases, University of California, Los Angeles, CA, USA.
Chelsea L ShoverDivision of General Internal Medicine and Health Services Research, University of California, Los Angeles, CA, USA. Electronic address: clshover@mednet.ucla.edu.
University of California, Los Angeles · US

Funding

Predicting fatal and non-fatal overdose in Los Angeles County with Rapid Overdose Surveillance Dashboard to target street-based addiction treatment and harm reduction servicesR01DA057630 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI David Goodman, Chelsea Leigh Shover · 2022 to 2026
$2.9M
Using data science to measure the impact of opioid agonist therapy in patients admitted with Staphylococcus aureus bloodstream infectionsK08DA048163 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GOODMAN, DAVID · 2019 to 2023
$1.0M
Adoption and scale-up of long-acting medications for opioid use disorder by U.S. clinicians.K01DA050771 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SHOVER, CHELSEA LEIGH · 2021 to 2025
$893k
NIDA NIH HHS K01 DA050771NIDA NIH HHS K08 DA048163NIDA NIH HHS R01 DA057630
6 · The paper itself

Abstract

backgroundHistorically, overdose mortality rates among Hispanics have been lower than non-Hispanics. The purpose of this analysis was to characterize the U.S. overdose crisis among Hispanics compared to non-Hispanics.

methodsWe used the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiological Research (WONDER) platform to obtain drug overdose mortality rates per 100,000 population between 2010 and 2021 for Hispanics and non-Hispanics. We examined the relative percent change and specific drug involvement (2010-2021) and state-level disparities (2010-2020) among Hispanics versus non-Hispanics. We calculated rate ratios by state and annual percent change in total and for each specific drug. Statistical analyses were performed using R software version 4.0.3 (R Project for Statistical Computing).

resultsNationally, from 2010 to 2021, Hispanic overdose rates rose from 5.6 to 21.7 per 100,000, an increase of 287.5 % compared to 13.5-35.1 per 100,000, an increase of 160 % among non-Hispanics. The average annual percent change was 12 % for Hispanics and 9 % for non-Hispanics. The three most common drug classes involved in overdose deaths among both groups included: Fentanyls and synthetic opioids; cocaine; and prescription opioids. Hispanic overdose rates were higher than non-Hispanic rates in New Mexico, Colorado, Massachusetts, and Pennsylvania in 2020, versus only Michigan in 2010.

conclusionsWe observed disparities in overdose mortality growth among Hispanics compared to non-Hispanics from 2010 to 2021. These disparities highlight the urgency to develop community-centered solutions that take into consideration the social and structural inequalities that exacerbate the effects of the opioid overdose crisis on Hispanic communities.

Indexed as

Analgesics, OpioidDrug OverdoseHispanic or LatinoCenters for Disease Control and Prevention, U.S.FentanylHumansNew MexicoUnited StatesAnalgesics, OpioidFentanylCocaineFentanylHispanicOpioidsOverdose

Identifiers

PMID37031488
PMCPMC11195918
OpenAlexW4361228967

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.